Chapter 44: Drugs for the Treatment of Parasites

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to the Deep Dive.

Today, we are shifting gears.

Usually when we talk about medicine, we think about fixing something that's broken inside us like a valve or a bone or maybe fighting off a bacteria or a virus.

But today, we are talking about a war.

And not a metaphorical war.

We are talking about a biological war that has been waging since, well, the dawn of life.

Exactly.

We are diving into chapter 44 of Brenner and Stevens Pharmacology.

The topic is the pharmacologic treatment of parasitic infections.

And looking at the source material, the first thing that hits you is just the sheer scale of this.

This isn't some niche problem, is it?

No, not at all.

I mean, we are talking about billions with a B of people infected globally.

And the definition of parasitism in the text really, it sets the stakes here.

It's not a symbiotic relationship where everyone gets along.

Right.

It is by definition a relationship where one species, the parasite, benefits entirely at the expense of the other, the host.

And in this scenario, we are the host.

Unfortunately, yes, we are the battlefield.

We provide the nutrients, the shelter, and the transport.

And in return, the parasite causes damage, it steals our energy, and sometimes it kills us.

It's a little unsettling when you put it that way.

But today, we are armed.

We are doing a last -minute lecture -style review of chapter 44.

We are going to walk through the pharmacological arsenal used to treat these infections.

And we aren't just skimming the surface.

We are going deep into the mechanisms, the drugs, and exactly how they work.

Because, as the text points out, killing a parasite is actually a lot harder than killing a bacteria.

That's a crucial insight to start with.

I mean, think about it.

Bacteria are prokaryotes.

They are biologically very, very different from humans.

They're cell walls.

They're ribosomes.

They are different enough that we can target them pretty easily without hurting our own cells.

But parasites, protozoa, worms.

Or eukaryotes, like us.

Exactly.

Their cellular machinery is uncomfortably similar to ours.

They have a nucleus.

They have mitochondria.

They have similar DNA structures.

So the challenge for pharmacology is this concept of selective toxicity.

How do you poison the invader without poisoning the host when you are built from almost the same blueprints?

It's like a sniper shot versus a carpet bomb.

You have to find the tiny differences and just exploit them.

Precisely.

And that's the lens we need to use for every single drug we discuss today.

What is the specific weakness in the parasite that we are exploiting?

Okay, so before we jump into the specific drugs, let's visualize the battlefield.

The text has this great diagram, figure 44 .1, that maps out where these drugs strike.

It's almost like a tactical map.

It really is.

If you look at that figure, you see that we are attacking the parasites on multiple fronts.

Some drugs, like the benzimidazoles, are attacking their physical structure, specifically their microtubules.

Others, like metronidazole, are basically sabotaging their DNA.

And then you have drugs like ivermectin or pyrrental that are attacking their nervous systems, causing paralysis.

And the text divides these invaders into two main camps.

You've got the endoparasites, the ones that actually get inside the body, like protozoa and helminths.

Which is just a fancy word for worms.

Right, worms.

And then the ectoparasites, the ones that hang out on the skin, like lysin mites.

Correct.

And while we have made remarkable advances over the last 50 years with drugs like albendazole and preziquantel, the text makes it very, very clear that the fight is far from over.

I mean, we still desperately need better, less toxic drugs for diseases like trypanosomiasis.

Okay, let's start with the first major group then.

The lumen and tissue -dwelling protozoa.

So basically, the microscopic invaders in the gut and the tissues.

The big three here are entomoeva histolytica, which causes amoebiasis, giardia intestinalis, which is responsible for giardiasis, and trichomonas vaginalis, which causes trichomoniasis.

I feel like everyone knows someone who's had giardia.

It's like the hiker's nightmare.

It is the most common parasitic infection in the United States.

You drink from a pristine looking stream on a hike thinking it's pure, but it's contaminated with cysts.

A week later, you have terrible diarrhea.

Lovely.

So when we look at the drugs for these three, there's a clear standout class that nitrimidazoles, specifically a pair of drugs that sound like siblings,

metronidazole and tinnidazole.

They are siblings, chemically speaking, and they are the heavy hitters.

If you go to the hospital with a protozoa infection in the gut, this is likely what you're getting.

Now, I love the mechanism here because it's like a Trojan horse or maybe a grenade is a better analogy.

A grenade is a very apt analogy.

See, these drugs are what we call pro drugs.

On their own, you know, floating around in your blood, they are relatively harmless.

They don't do much of anything, but they require a specific enzyme to become active.

And that enzyme is something we don't have, right?

Exactly.

The enzyme is called pyruvate ferredoxin oxidarductase, or PFOR for short.

It's found in anaerobic parasites organisms that thrive without oxygen.

When the drug enters the parasite, this PFOR enzyme tries to metabolize it.

It transfers an electron to the nitro group of the drug.

And that's the pin being pulled on the grenade.

It is.

This reduction reaction creates nitro -free radicals.

And as we know in biology, free radicals are basically molecular wrecking balls.

They are highly reactive.

They just go on a rampage inside the parasite, attacking its DNA, ripping apart its proteins and damaging cell membranes.

So the parasite effectively pulls the pin on the grenade itself just by trying to process the drug.

That is the perfect way to visualize it.

It causes a cytotoxic effect that essentially destroys the organism from the inside out.

And we're safe because we don't have that PFOR enzyme.

Exactly.

Humans lack that PFOR pathway.

We use mitochondria and aerobic metabolism so we don't generate those specific free radicals.

So we are relatively safe from this reaction.

That is fascinating.

It really highlights that concept of selective toxicity.

Now, functionally, is there a big difference between metronidazole and tinidazole?

The mechanism is identical, but the pharmacokinetics, how the body handles the drug, are different.

This is a key note for any students listening who might see this on an exam.

Tinidazole has a significantly longer half -life.

We're talking about 13 hours compared to just 8 hours for metronidazole.

So that means less frequent dosing.

Yes.

And typically, a shorter treatment duration.

For example, in GRD -ASIS, tinidazole can often cure the infection with a single large dose.

A single dose.

Whereas metronidazole usually requires dosing three times a day for five to seven days.

That's a huge difference in convenience.

If I have the choice between one pill or a week of pills, I know what I'm taking.

Absolutely.

Compliance is always, better with simpler regimens.

Let's talk about the specific clinical nuances here, starting with amoebiasis.

This is caused by entamoeba histolytica.

The text makes a really important distinction between the sort of hiding parasite and the invading parasite.

This is a classic board exam concept.

Entamoeba histolytica can exist in two states.

It can sit quietly in the gut lumen, the tube of the intestine as a cyst.

It's not causing symptoms there, but the person is a carrier.

Or it can wake up, become a trophozoate, burrow into the intestinal wall, enter the blood, and even travel to the liver to form an abscess.

The liver abscess sounds terrifying.

It is very serious.

Now, metronidazole and tinidazole are excellent tissue amoebicides.

They are well absorbed in the stomach, they get into the blood, and they penetrate tissues like the liver to kill those invaders.

However, and this is the crucial clinical pearl, they are not perfect at clearing the cysts that are just sitting in the gut lumen.

So you could cure the liver abscess, save the patient's life, but leave them still carrying the infection in their gut.

Exactly.

And that puts the patient at risk of relapse or, you know, spreading it to their family.

So for symptomatic amoebiasis, you use a one -two punch.

You give metronidazole to kill the tissue invaders, but you must follow it up with a luminal amoebicide.

The text points to paramomycin as that cleanup crew.

Right.

Paramomycin is an aminoglycoside antibiotic.

If you know your antibiotics, you know that aminoglycosides are notoriously poorly absorbed when taken orally.

Which, in this case, is exactly what we want.

Exactly.

You swallow it and it just stays in the gut tube.

It doesn't go into the blood.

It acts like a broom, just sweeping the cysts out of the gut lumen without causing systemic side effects.

So metronidazole for the tissue, paramomycin for the lumen.

Got it.

Now, what about the third member of the big three, trichomoniasis?

This one is different because it's a sexually transmitted disease.

It's caused by trichomonas vaginalis.

And the treatment protocol has a specific social rule attached to it.

It does.

Trichomonas often causes vaginitis and symptoms in women, but men are usually asymptomatic carriers.

They don't even know they have it.

So if you only treat the female patient, she goes home and her untreated partner reinfects her.

It's called ping pong reinfection.

So the hard and fast rule is you must treat both partners simultaneously to break the cycle.

Okay, so metronidazole and tenadazole are great drugs, but they come with some warnings.

I know there is one big one that you basically have to shout at the patient.

You absolutely do.

It is the disulfiram -like reaction.

Which translates to, put the wine glass down.

Put it down, pour it out, don't even look at it.

The text is very specific here.

These drugs inhibit the metabolism of acetaldehyde, which is a toxic byproduct of alcohol breakdown.

If a patient drinks alcohol while taking these drugs, acetaldehyde builds up in their blood instantly.

And this isn't just a, you might feel a bit tipsy warning.

This is, you will feel like you are dying.

Correct.

We are talking about severe nausea, projectile vomiting, flushing of the skin, erasing heart, and a sense of impending doom.

It is absolutely miserable.

You have to warn patients to avoid alcohol entirely during treatment, and for at least three days after the last dose to let the enzyme recover.

That is a critical safety point.

Are there other side effects?

A metallic taste in the mouth is very common, and quite annoying.

Also, these drugs can cross the placenta, so they are generally contraindicated in the first trimester of pregnancy due to potential effects on the fetus.

Okay, there is one more drug in this gut protozoa section.

Nidazoxanide.

Nidazoxanide is a broad spectrum agent.

It targets that same PFOR enzyme pathway we talked about with metronidazole, but it also blocks another pathway called pyruvate .ferredoxin, 2 -oxidoraductase.

Its main claim to fame is treating cryptosporidium.

That is the waterpark parasite.

That is the one.

It is highly resistant to chlorine.

You see outbreaks in community pools.

In healthy people, immunocompetent people, it causes diarrhea that usually goes away on its own, but Nidazoxanide speeds up recovery significantly.

But the text makes a sad distinction here regarding AIDS patients.

It does.

In immunocompromised patients, specifically those with AIDS,

cryptosporidiosis isn't just a nuisance.

It causes chronic, severe, life -threatening diarrhea.

Fluid loss can be massive.

Oh, wow.

And unfortunately, Nidazoxanide is not effectively curative for these patients.

It relies on the immune system to help out.

Exactly.

It inhibits the parasite, but your immune system needs to finish the job.

If you don't have a functional immune system, the drug fails.

So for AIDS patients, the primary treatment for cryptosporidiosis is actually antiretroviral therapy.

You have to rebuild the immune system so the body can fight the parasite itself.

That's a sobering reminder of the limits of pharmacology.

Okay, let's leave the gut and move to the blood.

We were stepping into the ring with the heavyweight champion of parasitic diseases, malaria.

The biggest killer.

Malaria is caused by plasmodium species.

The text highlights four.

P.

falciparum, P.

vivax, P.

oval, and P.

malaria.

The falciparum and vivax are the most common.

And to understand the drugs, we have to understand the life cycle.

Figure 44 .2 in the text is the roadmap here.

Can you walk us through it?

Because if we don't understand the map,

the drugs make no sense.

Certainly.

It starts with a mosquito bite.

An Anopheles mosquito bites you and injects the parasite in a form called sporozoites.

Now, these don't stay in the blood.

They head straight for the liver.

This is the ex -erythrocytic stage outside the red blood cell.

Correct.

In the liver, they invade hepatocytes, the liver cells, and they just multiply asexually.

They form these things called tissue schizones.

This is the incubation period.

You don't feel sick yet.

Right.

Eventually, these liver cells burst, releasing thousands of merozoites into the bloodstream.

And that kicks off the erythrocytic stage, the blood stage.

Right.

The merozoites invade your red blood cells.

They consume the hemoglobin, they multiply, and then they burst the red blood cell.

That bursting releases toxins and more parasites, which causes the massive fever spikes and chills that are characteristic of malaria.

Now, the text mentions a sleeping danger with P.

vivax and P.

ovul.

Yes.

This is crucial for drug selection.

P.

felsiperum goes into the liver, multiplies, and leaves.

It doesn't look back.

But P.

vivax and P.

ovul can leave a dormant form behind in the liver, all a hypnozoate.

Hypnozoite, like hypnosis.

Sleeping.

Exactly.

These hypnozoites can hibernate in your liver for months or even years.

Then, triggered by stress or just time, they wake up, multiply, and invade the blood again.

So you could treat the patient, cure the fever, think they were fine, and then six months later, bam, malaria again.

Precisely.

That is a relapse.

And this brings us to our first drug class, the liver specialist.

And that drug is Primakine.

What makes Primakine the specialist?

Primakine is the only available drug that effectively kills those latent hypnozoites in the liver.

It is a tissue schizonticide.

If you have a patient with P.

vivax or P.

ovul, you must use Primakine to eradicate the liver infection or you are not actually curing them.

You're just pausing the disease.

But you usually pair it with something else.

Yes.

Because Primakine isn't strong enough to clear the active blood infection quickly.

So you use a blood stage drug, like chloroquine, to save the patient from the acute illness and Primakine to clear the liver and prevent future relapse.

Now Primakine has a major safety alert attached to it involving G6PD.

This sounds like a medical mystery.

It is a classic pharmacology board exam question.

Primakine works by generating reactive oxygen species oxidative stress that interferes with the parasite's electron transport.

But that oxidative stress also affects the patient's red blood cells.

And we have a defense against that.

Ideally,

yes.

Humans have an enzyme called glucose -6 -phosphate dehydrogenase, or G6PD.

Its job is to generate NADPH, which helps protect red blood cells from oxidative damage.

It's like the bodyguard.

But some people don't have enough of the bodyguard.

Exactly.

G6PD deficiency is a common genetic condition, particularly in populations where malaria is endemic.

If you give Primakine to a patient with G6PD deficiency, their red blood cells cannot handle the oxidative stress.

The cells rupture.

Which causes hemolytic anemia.

Severe anemia.

Dark urine.

Fatigue.

Jaundice.

So the rule is mandatory.

You must test a patient's G6PD status before prescribing Primakine.

Got it.

Okay, let's move to the blood stage fighters.

The most famous one historically is chloroquine.

Chloroquine was the king for decades, and its mechanism is fascinatingly specific to the parasite's diet.

The parasite eats hemoglobin, right?

It does.

It lives inside the red blood cell, and it devours hemoglobin for amino acids.

But there's a problem for the parasite.

Hemoglobin contains heme, an iron -containing molecule.

Free heme is highly toxic.

It creates free radicals that would kill the parasite.

So the parasite is eating a poison sandwich.

Effectively.

So the parasite has evolved a coping mechanism.

It has an enzyme that polymerizes the heme.

It stacks the toxic heme molecules into an inert, non -toxic crystal called hemozoin.

It takes out its own trash.

Exactly.

Now, enter chloroquine.

Chloroquine concentrates inside the parasite's food vacuole, and it blocks that polymerization process.

It prevents the parasite from stacking the heme.

So the toxic heme builds up.

Yes.

The heme accumulates, the free radicals fly, and the parasite essentially poisons itself with its own dinner.

That is such an elegant mechanism.

Why don't we use it all the time?

Evolution.

The parasites, they figured it out.

They developed genetic mutations, specifically in a transporter called PFCRT, that allows them to pump the drug out of the food vacuole.

Chloroquine is now virtually useless against P.

falciparum in most of the world Africa, Southeast Asia, South America.

It works in a few zones, like the Caribbean, and parts of Central America west of the Panama Canal.

But generally, the king has fallen.

So if chloroquine is out for severe malaria,

what's the new heavyweight champion?

The artemisinin derivatives, artesanate and artemether.

These come from a plant, right?

Yes.

Artemisia annua, or sweet wormwood.

It has been used in traditional Chinese medicine for 2 ,000 years to treat fevers.

It was rediscovered by scientists in the 1970s.

How did that work?

They are the rapid responders.

Chemically, they contain an endoperoxide bridge structure.

When this structure comes into contact with the iron in the heme inside the parasite, that bridge breaks.

And it explodes.

Chemically, yes.

It generates highly reactive carbon -free radicals that alkylate and damage the parasite's proteins and macromolecules.

There's that free radical theme again.

We are bombing them.

It's a very effective weapon.

These drugs work incredibly fast to lower the parasite count in the blood.

They are now the first -line treatment for severe malaria.

But there is a golden rule in modern malaria treatment.

Never use them alone.

Why not?

To prevent resistance.

If you use artemisinin alone, you might kill 99 % of the parasites, but the strongest 1 % might survive and breed.

By pairing it with a partner drug that has a different mechanism and a longer half -life, you ensure the job is finished.

This is called ACT, right?

Yes, artemisinin -based combination therapy.

For example, artemether is paired with lumifantrine.

Artemisinin hits fast and hard.

Lumifantrine sticks around longer to mop up the survivors.

It's the standard of care now.

Before we leave malaria, let's touch on mefloquine.

Mefloquine is effective, but it has a bit of a reputation.

It's a blood schizonticide used for prophylaxis and treatment in resisting areas.

However, the text notes a black box -style warning regarding neuropsychiatric effects.

Anxiety, vivid nightmares, depression, hallucinations, and confusion.

While severe reactions are rare, they are serious.

You have to screen your patients.

If someone has a history of depression or psychiatric issues, mefloquine is not the drug for them.

And finally, malarone.

That's a combination of autovaquone and proguanol.

It inhibits mitochondrial electron transport and folate synthesis.

It's very popular for travelers taking prophylaxis because it's well -tolerated and works against resistance strains.

Okay, moving on from malaria to the other protozoan infections.

Section 3 of our outline.

Let's start with toxoplasmosis.

Toxoplasma gondii.

This is the one associated with cats.

And pregnant women are always told to avoid changing the litter box.

Why is that?

It comes back to the risk to the fetus.

If a woman gets infected during pregnancy, meaning a primary infection, the parasite can cross the placenta.

It causes congenital toxoplasmosis, which can lead to hydrocephaly, which is water on the brain, blindness, and severe mental disability.

But if she had cats her whole life.

Then she likely has antibodies already.

The risk is the new infection.

And the treatment listed is perimethamine plus sulfonamides, like sulfadiazine.

But there's a note here about thalinic acid rescue.

Right.

Perimethamine works by inhibiting the enzyme dihydrofolate reductase.

It stops the production of folate, or vitamin B9.

Cells need folate to make DNA and divide.

That kills the parasite.

Yes.

But human bone marrow cells also need folate to make red and white blood cells.

Perimethamine doesn't know the difference.

It suppresses the bone marrow.

So how do we protect the patient?

We add thalinic acid, also called leukovorin.

This is a form of folate that bypasses the metabolic block.

Human cells can uptake this rescue folate and use it to survive.

The parasite, however, lacks the transporter to use exogenous folate effectively.

That is incredibly clever.

We are starving the enemy while smuggling food to our own troops.

Exactly.

Next up is a bug that has a bit of an identity crisis.

Pneumocystis giuroveci.

Or PCP.

The text clarifies that while we used to think it was a protozoan, we now know it's actually a fungus.

True.

But historically and clinically, we group it here because it doesn't respond to standard antifungals.

It responds to antiparasitic -style drugs.

PCP is a major opportunistic infection in AIDS patients.

It causes a severe suffocating pneumonia.

And the treatment of choice is an antibiotic combo.

Yes.

TMPSMX, which is trimethoprimsulfamethoxazole.

It blocks folate synthesis at two different steps.

It's the gold standard for both treatment and prevention in HIV patients.

And if they have a sulfa allergy or can't take that?

The alternative is pentamidine.

It inhibits DNA replication.

It can be given IV for severe cases.

But interestingly, it can also be inhaled as a nebulized treatment for prephylaxis.

You can inhale it.

Yeah, by inhaling it, you get high concentrations in the lungs where the fungus lives with less systemic toxicity.

Moving to the really scary tropical diseases.

Trypanosomiasis.

We have African sleeping sickness and Chagas disease.

These are nasty infections.

African sleeping sickness is transmitted by the tsetse fly.

The parasite enters the blood and eventually crosses the blood -brain barrier into the central nervous system.

Hence, sleeping sickness.

Right.

It disrupts the sleep -wake cycle, leading to confusion, coma, and then death.

And the drugs.

Pentamidine is used for the early stage, the hemolymphatic stage.

But once it hits the brain, pentamidine doesn't cross the blood -brain barrier well enough.

For the late CNS stage, we use efflornathine.

The text mentions something remarkable about efflornathine.

It has been described as resurrecting patients.

People who are comatose on the brink of death can wake up and recover.

It inhibits an enzyme called ornithine decarboxylase, which the parasite needs for cell division.

That's incredible.

And Chagas disease.

That's American trypanosomiasis.

It's found in Central and South America, transmitted by the redovid bug.

Also known as the assassin bug or kissing bug.

Because it tends to bite the face at night, Chagas is a chronic disease that can lead to massive heart failure or cardiomyopathy and megasophagous years after infection.

The drug of choice is nifertimox.

It generates free radicals.

Again, that theme.

It's effective for acute infection, but toxicity is a problem.

And it's less effective in the chronic stage.

The last protozoan on our list is leishmaniasis.

And the text has a specific case study here, box 44 .1.

Yes, the story of the embassy official in Afghanistan.

He developed these spreading ulcerated sores on his cheek and arms after being bitten by sandflies.

Sandflies are the vector here.

Correct.

This is cutaneous leishmaniasis.

Now, historically, the treatment for this was antimony compounds, heavy metals.

Imagine getting injections of a heavy metal.

It sounds toxic.

It was.

Pancreatitis, cardiac issues, severe muscle pain.

You had to go to hospital to get it 5E.

But this case study highlights the breakthrough drug.

Miltifosing.

What makes Miltifosing a game changer?

It is the first effective oral drug for leishmaniasis.

It's a pill.

No needles.

No needles.

It was originally developed as an anti -cancer drug, but failed in trials.

However, they found it inhibits the parasite's membrane lipid metabolism.

It induces apoptosis cell suicide in the parasite.

And the cure rate.

For visceral leishmaniasis, which is the deadly internal form, it has a 94 to 97 % cure rate.

It transformed a treatment that required hospitalization and toxic injections into something you can take by mouth at home.

That is massive progress.

That's huge.

All right.

Let's shift gears entirely.

We are done with the single -celled organisms.

It's time for the worms.

The helminths.

And we start with the nematodes, or roundworms.

Things like Ascaris, the giant roundworm, Enterobius, which is pinworms, and hookworms.

If you have a roundworm infection, chances are you're getting a benzimidazole.

That's albendazole or mbendazole.

These are the mainstays, and their mechanism is purely structural.

The text mentions microtubules.

Think of microtubules as the skeleton and the highway system of a cell.

They are made of Lego blocks called tubulin.

Cells constantly build up and break down these highways to move nutrients into divide.

So how do the drugs work?

Benzimidazoles bind specifically to the parasite's beta -tubulin.

They act like a capped Lego block.

They cap the end of the chain and stop the worm from adding more pieces.

The microtubules just dissolve.

And what does that do to the worm?

It's catastrophic.

Specifically, the worm's gut cells rely on microtubules to uptake glucose.

When the microtubules collapse, the gut stops working.

The worm cannot absorb sugar.

So it starves to death.

Yes.

It starves and becomes immobilized because its muscles also rely on that structure.

It's a slow death that takes a few days.

Now, there is a very specific pharmacokinetic tip in the text about albendazole.

It says, take with a fatty meal.

But wait, you only do that sometimes.

This is where you have to be a smart clinician.

Albendazole is poorly absorbed on an empty stomach.

If you are treating a worm that is living in the gut lumen, like a pinworm or a hookworm, you don't want the drug to leave the gut.

You want it to stay there and hit the worm.

So you take it on an empty stomach.

But if the worm is in your tissues?

Exactly.

Like in cysticercosis or a hydrated disease where the cysts are in the brain or liver, then you need the drug in the blood.

A fatty meal increases the absorption of albendazole by up to fivefold.

So for tissue infections,

pass the butter.

That is a crucial distinction.

Also, because these drugs inhibit cell division via microtubules, the text warns they are strictly contraindicated in pregnancy.

Yes.

They are teratogenic, meaning they cause birth defects in animals.

You avoid them in pregnancy, especially the first trimester.

Next up in the nematode section is a drug that has won a Nobel Prize.

Ivermectin.

An absolute wonder drug.

It targets anchocerca volvulus, the worm that causes river blindness, and also strongeloids.

How does it work?

It's different from the starvation mechanism, right?

Very different.

Ivermectin targets the nervous system of the worm.

It binds to glutamate -gated chloride channels.

We don't have those, do we?

Not in our peripheral nerves.

We have them in our brain, but Ivermectin is a big molecule, and there are P -glycoprotein pumps that keep it out of the human brain.

The worm, however, has them in its muscles and nerves.

So what happens when it binds?

It locks the channel open.

Chloride, which is negatively charged, rushes into the nerve cell.

So the cell becomes super negative.

Hyperpolarized.

It turns the nerve off.

The worm suffers flaccid paralysis.

It can't move, it can't eat, and it dies.

The text calls it a river blindness miracle.

It is.

River blindness is caused by the larvae, the micro filariae, of the ancho -circa worm migrating through the skin and eyes.

The immune reaction creates scarring that leads to blindness.

Ivermectin kills these larvae effectively.

And the dosing is incredible.

A single dose, once a year, it clears the larvae.

It doesn't kill the adult worm, which is deeply hidden in nodules, but by killing the larvae, it stops the blindness and stops the transmission.

It has saved the sight of millions of people in Africa and Latin America.

And there is a newer cousin mentioned, moxodectin.

Yes, moxodectin works by the same mechanism, but has a longer half -life.

It suppresses the larvae for longer, which might be helpful in finally eradicating the disease.

Let's move to section five.

The trimatodes, or flukes and cestos, which are tapeworms.

Here we have one drug that rules them all.

Praziquantel?

It's the magic bullet.

It really revolutionized the treatment of sexosomiasis, or blood flukes, in almost all tapeworms.

Before this, the treatments were toxic and pretty ineffective.

The mechanism here is a double whammy.

It starts with calcium.

It does.

Praziquantel increases the permeability of the worm's cell membrane to calcium ions.

Calcium rushes into the worm's muscle cells.

And calcium triggers muscle contraction.

Exactly.

So the worm instantly suffers a massive titanic muscle spasm.

It curls up into a ball and paralysis sets in.

If it's a schistosome clinging to the wall of your blood vessel against the blood flow, it just lets go and washes downstream to the liver.

But the second effect is the one I found even more interesting.

It mentions unmasking.

This is the genius of the drug.

Schistosomes are masters of disguise.

They cover themselves and host proteins to hide from your immune system.

They are essentially invisible to your white blood cells.

And praziquantel ruins the disguise.

The calcium influx and the spasms damage the tegument, the skin of the worm.

It causes vacuolization, which is like blistering.

This disrupts that coating and exposes the worm's unique antigens.

So it reveals the enemy to the army.

Yes.

It allows the host's immune system to finally see the worm and attack it.

So it's a drug that actually recruits your own immune system to help finish the job.

That is brilliant.

Clinically, what do we use it for?

Schistosomiasis, obviously.

But also tapeworms like Taminia solium.

For a simple intestinal tapeworm, a single dose often clears it.

But for something like neurocysticercosis, where they pork, tapeworm, larva form cysts in the brain, it's more complex.

Because killing a cyst in the brain sounds dangerous.

It is.

As the cyst dies from the drug, it releases inflammatory antigens.

The brain swells.

This can cause seizures.

So you have to treat with praziquantel plus high -dose steroids like dexamethasone to control the inflammation while the cyst dies.

And just a quick mention of triclobendazole.

Yes, that's a niche drug specifically for the sheep -liver fluke, fascidola hepatica.

Interestingly, praziquantel doesn't work well on that specific fluke because its tegument is too thick or different.

So we use triclobendazole, which interferes with tubulin.

Finally, let's scratch the surface pun intended of section 6.

Ectoparasites.

Lice and scabies.

The creepy crawlies.

Pediculosis, which is lice.

And scabies, which are mites.

The classic treatment has been permethrin.

Permethrin is a synthetic pyrethroid similar to compounds found in chrysanthemums.

It targets the sodium channels in the insect's neurons.

Sodium channels are the on switch for nerves.

Permethrin binds to the channel and keeps it open.

It prevents it from closing, from repolarizing.

So the nerve fires repeatedly and uncontrollably.

The insect suffers spasms, paralysis, and death.

It's usually a cream or shampoo.

Yes.

For head lice, you apply it for 10 minutes and rinse.

For scabies, which burrow under the skin, you apply a full body cream and leave it on for 8 to 14 hours, usually overnight.

But resistance is a problem here too.

Massive resistance.

Super lice are now common in many schools.

The sodium channels have mutated so the drug doesn't bind as well.

Which brings us to the newer agent.

Spinosad.

Spinosad is a really cool discovery.

It comes from the fermentation of a soil actinomycete bacterium.

A natural product.

Yes.

It works by activating nicotinic acetylcholine receptors in the insect.

This causes muscle contraction and paralysis.

But here is the big benefit for parents that the text highlights.

It is ovicidal.

It kills the eggs.

Yes.

With permethrin, it kills the live lice, but the nits, the eggs, often survive.

You have to comb them out with a fine -toothed comb, which is tedious and painful.

Spinosad kills the lice and the eggs.

No nit -combing?

No nit -combing required.

That is a huge practical advantage for parents.

And there is one newest agent mentioned.

Abometapyr.

This is a lotion.

It inhibits metalloproteinous.

These are enzymes the lice need for egg development and hatching.

It's another tool in the box as resistance grows.

So we've covered a lot of ground today.

From nitroradicals blowing up amoebas in the gut to primocene clearing the liver of malaria to starving worms with albendazole and paralyzing lice with soil bacteria.

It really is a tour de force of pharmacology.

As we wrap up, what's the big takeaway for you from chapter 44?

For me, it comes back to that concept we started with.

Selective toxicity and the evolutionary arms race.

All these drugs rely on finding a tiny biological difference between us and the parasite.

We don't have PFOR enzymes.

They do.

We don't have glutamate -gated chloride channels.

They do.

We don't build our microtubules exactly the same way.

But as they evolve, they change those targets.

Exactly.

Resistance is simply the parasite evolving to close those gaps.

They change the shape of the sodium channel.

They pump out the coracuin.

The hunt for these tiny differences is getting harder.

It's an arms race.

We develop a weapon.

They develop a shield.

And in cases like malaria, they are evolving very, very fast.

It's a sobering thought, but also a call to action.

We need new drugs and new targets.

Absolutely.

The war is far from over.

Well, thanks for joining us on this deep dive into the microscopic battlefield.

This has been the Last Minute Lecture Team.

Good luck with your studies.

And remember, wash your hands and cook your food.

Wise words.

See you next time.